Erratum to: Efficacy and Safety of Intravenous-to-oral Lefamulin, a Pleuromutilin Antibiotic, for the Treatment of Community-acquired Bacterial Pneumonia: The Phase III Lefamulin Evaluation Against Pneumonia (LEAP 1) Trial
Current Language EN
English English Türkçe Türkçe Español Español Português Português Pусский Pусский Filipino Filipino Tiếng Việt Tiếng Việt हिन्दी हिन्दी العربية العربية বাংলা বাংলা Deutsch Deutsch 中文 中文

Erratum to: Efficacy and Safety of Intravenous-to-oral Lefamulin, a Pleuromutilin Antibiotic, for the Treatment of Community-acquired Bacterial Pneumonia: The Phase III Lefamulin Evaluation Against Pneumonia (LEAP 1) Trial

File, Thomas M;Goldberg, Lisa;Das, Anita;Sweeney, Carolyn;Saviski, John;Gelone, Steven P;Seltzer, Elyse;Paukner, Susanne;Wicha, Wolfgang W;Talbot, George H;Gasink, Leanne B;
clinical infectious diseases 2020 Vol. 70 pp. 2459-2459
178
m2020clinicalerratum

Abstract

The following error appeared in the corrected proof publication of this article [File TM, Goldberg L, Das A, et al. Efficacy and Safety of Intravenous-to-oral L

Keywords

Access

URL:
https://academic.oup.com/cid/article-abstract/70/1...

Citation

ID: 110664
Ref Key: m2020clinicalerratum
Use this key to autocite in SciMatic or Thesis Manager

References

References

No Bibliography

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
110664
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet
Gas fees required in SCI Coins
Buy SCI

Saymatik Web3.0 Wallet

Google Play
App Store